• Company
• Jemperli can be prescribed at general hospitals in KOR
• by Eo, Yun-Ho Mar 11, 2024 05:55am

• Company
• Hemlibra shows big sales rise, Advate loses ground
• by Kim, Jin-Gu Mar 11, 2024 05:55am

• Company
• AZ’s EGPA drug Fasenra receives orphan drug designation
• by Eo, Yun-Ho Mar 11, 2024 05:55am

• Policy
• 1st KOR trial of 'STX-721' to treat EGFR mutant NSCLC begins
• by Lee, Hye-Kyung Mar 11, 2024 05:55am

• Policy
• Fasenra's reimb application passes DREC review
• by Lee, Tak-Sun Mar 11, 2024 05:55am

• Policy
• Pfizer starts trial for its RSV drug sisunatovir on adults
• by Lee, Hye-Kyung Mar 8, 2024 05:19am

• Policy
• Pharmas impacted by ‘minoxidil’ bioequivalence test result
• by Lee, Hye-Kyung Mar 8, 2024 05:18am

• Policy
• CSL Behring’s hemophilia B Tx Idelvion reattempts reimb
• by Lee, Tak-Sun Mar 8, 2024 05:18am

• Company
• Anemia drug ‘Vadanem’ makes 2nd attempt at reimb listing
• by Nho, Byung Chul Mar 8, 2024 05:18am

• Policy
• 2yr use restriction lifted for Alimta+Keytruda combo reimb
• by Lee, Tak-Sun Mar 8, 2024 05:18am